The project, focuses on confirming the baseline value proposition of a novel receptor scaffold technology by showcasing superior features of the firm's T-cell product compared to standard of care in...
12343096 CANADA INC.
7 enregistrements totalisant 822,248.95 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $822,249 | 7 enregistrements |
Enregistrements
In this project, we will analyze the performance of two novel CAR constructs against the current standard of care CAR construct within physiologically relevant mouse models to demonstrate superior tre...
This project focuses on the development and testing of novel synthetic immune receptors for cancer and beyond.
Research and development in virus-like particles for uses with in vivo cell therapy applications.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Rese...
Participation in the Canadian medical biotechnology co-innovation mission to the Eureka Global Innovation Summit and Swiss Biotech Day in Switzerland – May 3 to 8, 2026. Delegation led by the National...